Longeveron Inc.

Nasdaq:LGVN

Pharmaceutical Preparations·MIAMI, FL

Financials

20 shown

Type	Period	Ended	Filed
10-Q	Q3 2025	9/30/25	11/4/25	→
10-Q	Q2 2025	6/30/25	8/13/25	→
10-Q	Q1 2025	3/31/25	5/8/25	→
10-K	FY 2024	12/31/24	2/28/25	→
10-Q	Q3 2024	9/30/24	11/12/24	→
10-Q	Q2 2024	6/30/24	8/14/24	→
↓

Earnings Releases (8-K)

16 shown

Filed	Period
11/4/25	Q4 FY2025	→
8/13/25	Q3 FY2025	→
5/8/25	Q2 FY2025	→
2/28/25	Q4 FY2024	→
11/12/24	Q4 FY2024	→
8/14/24	Q3 FY2024	→
↓

News (8-K)

64 shown

Filed	Type	Description
2/13/26	Exec Change	Departure or Appointment of Directors or Certain Officers	→
11/12/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
10/1/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
9/26/25	Delisting	Notice of Delisting or Failure to Satisfy a Continued Listing Rule	→
9/19/25	Agreement	Entry into a Material Definitive Agreement	→
9/3/25	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

40 shown

Filed	Form	Description
9/19/25	424B5	PROSPECTUS SUPPLEMENT	→
8/11/25	424B4	424B4	→
8/8/25	S-1/A	AMENDMENT NO. 1 TO FORM S-1	→
8/4/25	S-1	REGISTRATION STATEMENT	→
6/20/25	S-8	REGISTRATION STATEMENT	→
4/28/25	ARS	FORM ARS	→
↓

Filing History(453 filings)

TypeDateAccessionPeriodSize

PRE 14A

Mar 3, 2026

0001213900-26-022706PROXY STATEMENT

Mar 3, 2026

2.4 MB

8-K

Feb 13, 2026

0001213900-26-016519CURRENT REPORT

Feb 9, 2026

312.1 KB

SCHEDULE 13G/A

Feb 10, 2026

0001493152-26-005948

—

6.6 KB

Jan 6, 2026

0001214659-26-000206PRIMARY DOCUMENT

Jan 2, 2026

4.9 KB

Jan 6, 2026

0001214659-26-000205PRIMARY DOCUMENT

Jan 2, 2026

4.9 KB

Jan 6, 2026

0001214659-26-000204PRIMARY DOCUMENT

Jan 2, 2026

4.9 KB

Jan 6, 2026

0001214659-26-000203PRIMARY DOCUMENT

Jan 2, 2026

4.9 KB

Jan 6, 2026

0001214659-26-000202PRIMARY DOCUMENT

Jan 2, 2026

4.9 KB

8-K

Nov 12, 2025

0001213900-25-108533CURRENT REPORT

Nov 7, 2025

186.5 KB

8-K

Nov 4, 2025

0001213900-25-106117CURRENT REPORT

Nov 4, 2025

298.3 KB

10-Q

Nov 4, 2025

0001193125-25-26460410-Q

Sep 30, 2025

8.3 MB

Oct 27, 2025

0001214659-25-015389PRIMARY DOCUMENT

Oct 1, 2025

4.8 KB

Oct 27, 2025

0001214659-25-015388PRIMARY DOCUMENT

Oct 1, 2025

7.6 KB

Oct 3, 2025

0001214659-25-014619PRIMARY DOCUMENT

Oct 1, 2025

4.9 KB

Oct 3, 2025

0001214659-25-014618PRIMARY DOCUMENT

Oct 1, 2025

4.9 KB

Oct 3, 2025

0001214659-25-014617PRIMARY DOCUMENT

Oct 1, 2025

4.9 KB

Oct 3, 2025

0001214659-25-014616PRIMARY DOCUMENT

Oct 1, 2025

4.9 KB

Oct 3, 2025

0001214659-25-014615PRIMARY DOCUMENT

Oct 1, 2025

4.9 KB

Oct 1, 2025

0001214659-25-014463PRIMARY DOCUMENT

Sep 4, 2025

7.1 KB

Oct 1, 2025

0001214659-25-014462PRIMARY DOCUMENT

Sep 4, 2025

8.7 KB

8-K

Oct 1, 2025

0001213900-25-094710CURRENT REPORT

Sep 25, 2025

204.7 KB

8-K

Sep 26, 2025

0001213900-25-092316CURRENT REPORT

Sep 22, 2025

194.5 KB

8-K

Sep 19, 2025

0001213900-25-089595CURRENT REPORT

Sep 19, 2025

506.0 KB

424B5

Sep 19, 2025

0001213900-25-089589PROSPECTUS SUPPLEMENT

—

660.0 KB

8-K

Sep 3, 2025

0001213900-25-084112CURRENT REPORT

Aug 27, 2025

221.4 KB

25 filings shown

Longeveron Inc.

Financials

Earnings Releases (8-K)

News (8-K)

Prospectuses & Registrations

Filing History(453 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
3/3/26	PRE 14A	PRE 14A	→
4/28/25	DEFA14A	ADDITIONAL MATERIALS	→
4/28/25	DEF 14A	DEF 14A	→
5/20/24	DEFA14A	DEFINITIVE ADDITIONAL MATERIALS	→
5/20/24	DEF 14A	DEF 14A	→
2/5/24	DEF 14A	DEF 14A	→
↓

Filed	Form	Description
1/6/26	4	PRIMARY DOCUMENT	→
1/6/26	4	PRIMARY DOCUMENT	→
1/6/26	4	PRIMARY DOCUMENT	→
1/6/26	4	PRIMARY DOCUMENT	→
1/6/26	4	PRIMARY DOCUMENT	→
10/27/25	4	PRIMARY DOCUMENT	→
↓

Filed	Form	Description
2/10/26	SCHEDULE 13G/A	SCHEDULE 13G/A	→
8/27/25	SCHEDULE 13G	SCHEDULE 13G	→
8/15/25	SCHEDULE 13G	SCHEDULE 13G	→
8/8/25	EFFECT	EFFECT	→
7/21/25	DRS	DRS	→
5/29/25	144	144	→
↓